Antiseptic Alcohol Swabs Recalled Due to Improper Storage Conditions
McKesson is recalling Dynarex Alcohol Swabsticks nationwide because products were stored outside the conditions specified on the drug label.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is a manufacturing compliance deviation (improper storage) without documented evidence of product harm, classifying this as a precautionary recall.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Dynarex Alcohol Swabsticks, an over-the-counter antiseptic product. The swabs are packaged as 50 4-inch saturated individual packets per box.
The recall was initiated due to Good Manufacturing Practice (CGMP) deviations: products were stored outside the conditions specified on the drug label. The affected product includes NDC 67777-300-01 (current) and NDC 67777-120-10 (discontinued), with Part# 1203. Distribution was nationwide in the United States.
The recalled product
- Product
- ALCOHOL (ALCOHOL)
- Brand
- ALCOHOL
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Topical Antiseptic
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Part# 1203
UPCs (2)
- 0616784120324
- 0616784120423
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27